First Command Advisory Services’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17
Closed -$642 649
2025
Q1
$642 Buy
+17
New +$1.36K ﹤0.01% 579

Other funds holding PCVX

First Command Advisory Services's PCVX Position: Q2 2025 in Review

First Command Advisory Services sold out of Vaxcyte (PCVX) in Q2 2025, closing a stake of 17 shares — an estimated $642 sold.

First Command Advisory Services first reported a position in PCVX in Q1 2025 and held it in 1 quarter. The position peaked at $642 in Q1 2025. 294 funds tracked by Wall St. Rank hold PCVX as of Q2 2025.

  • First Command Advisory Services reported no remaining Vaxcyte position as of Q2 2025 after selling out during the quarter.
  • First Command Advisory Services sold 17 Vaxcyte shares in Q2 2025, an estimated $642.
  • First Command Advisory Services first reported a position in Vaxcyte in Q1 2025 and held it in 1 quarter.
  • First Command Advisory Services's Vaxcyte position peaked at $642 in Q1 2025.
  • 294 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2025.

Based on First Command Advisory Services's 13F filing for Q2 2025, filed 1 Aug 2025.